SBC Stock Analysis: Buy, Sell, or Hold?
SBC - SBC Medical Group Holdings Incorporated Common Stock
$3.07
-0.13 (-4.06%)
▼
5d:
-0.97%
30d:
-6.4%
90d:
-19.42%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When SBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SBC shows positive signals but monitor for confirmation. Market pricing in 7.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SBC shows positive signals but monitor for confirmation. Market pricing in 7.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.81
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$2.99
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBC is currently trading at $3.07, which is considered slightly low relative to its 30-day fair value range of $3.04 to $3.30. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.3) compared to its historical average (8.1). Remarkably, the market is currently pricing in an annual earnings decline of 7.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBC is in a strong downtrend. Immediate support is located at $2.86, while resistance sits at $3.55. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+176.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBC is in a strong downtrend. Immediate support is located at $2.86, while resistance sits at $3.55. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+176.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.04 -
$3.30
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.1%)
- BULLISH: Trading 176.9% below Wall St target ($8.50)
Trading Range Analysis
30-Day Trading Range
$3.04 -
$3.30
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.86
Resistance Level
$3.55
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.33
Wall Street Target
$8.50
(+176.9%)
Revenue Growth (YoY)
-9.0%
Earnings Growth (YoY)
-47.1%
Profit Margin
24.1%
Valuation Discount vs History
-7.7% cheaper
PE vs Historical
6.3 vs 8.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.7%
(market-implied from PE analysis)
1-Year Target
$2.83
(-8%)
2-Year Target
$2.62
(-15%)
3-Year Target
$2.41
(-21%)
3-Yr Target (if PE normalizes)
(PE: 6→8)
$3.09
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 4.3%)
$12.06
(+293%)
Base:
(SPY PE: 6.3, Growth: 4.3%)
$3.48
(+14%)
Bear:
(PE: 5.4, Growth: 4.3%)
$2.96
(-4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (8x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Trailing PE: 7.75 | Current EPS (TTM): $0.40
Bull Case
$4.13
(+30%)
Analyst growth 21.2%, PE expands to 8.5
Base Case
$3.76
(+18%)
Market implied 21.2%, PE stable at 7.8
Bear Case
$2.11
(-34%)
Severe decline -20.0%, PE contracts to 6.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.3 to 8.1
Stabilization Target:
$3.93
(+28.0%)
PE Expansion Potential:
+28.0%
Share & Embed Analysis
Last updated: June 04, 2026 1:26 AM ET
Data refreshes hourly during market hours. Next update: 2:26 AM
Data refreshes hourly during market hours. Next update: 2:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Yoshiyuki Aikawa
SELL
3100000 shares
2026-04-21
Yoshiyuki Aikawa
SELL
4422900 shares
2026-03-06
Top Rated Consulting Services Stocks
Top-rated stocks in Consulting Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EFX
Equifax Inc |
BUY
23 analysts |
$224 | 63 BUY |
|
HURN
Huron Consulting Group I… |
STRONG BUY
5 analysts |
$206 | 61 BUY |
|
VRSK
Verisk Analytics Inc |
HOLD
18 analysts |
$220 | 59 HOLD |
|
BAH
Booz Allen Hamilton Hold… |
HOLD
14 analysts |
$96 | 61 BUY |
|
ICFI
ICF International Inc |
BUY
5 analysts |
$105 | 59 HOLD |
